Related Experiment Videos
Chronic obstructive pulmonary disease: new opportunities for drug development
1National Heart and Lung Institute, Imperial College School of Medicine, London, UK.
Trends in Pharmacological Sciences
|November 6, 1998
Summary
New research explores novel therapeutic targets for chronic obstructive pulmonary disease (COPD), a common respiratory illness with increasing global prevalence. This review discusses potential new drugs to address this neglected disease and prevent airflow obstruction progression.
Area of Science:
- Pulmonary Medicine
- Pharmacology
- Molecular Biology
Background:
- Chronic obstructive pulmonary disease (COPD) is a prevalent respiratory condition with rising global incidence.
- Current treatments do not halt the progression of airflow obstruction in COPD patients.
Purpose of the Study:
- To review emerging therapeutic targets for COPD based on recent molecular and cellular mechanism discoveries.
- To discuss potential novel pharmacological interventions for COPD management.
Main Methods:
- Literature review of recent research on COPD pathogenesis.
- Analysis of identified molecular and cellular targets for drug development.
Main Results:
- Understanding of COPD's molecular and cellular underpinnings has revealed new therapeutic targets.
- Key targets include inflammatory mediators, proteases, and adhesion molecules.
Conclusions:
- Novel drug development holds promise for treating COPD.
- Addressing therapeutic targets could lead to treatments that prevent disease progression.